tiprankstipranks
Advertisement
Advertisement

REGN Stock Latest News

Regeneron, Sanofi get approval for Dupixent to treat bullous pemphigoid in Japan
The FlyRegeneron, Sanofi get approval for Dupixent to treat bullous pemphigoid in Japan
2d ago
SNY
REGN
Get Ready for a $5.7 Trillion ‘Triple-Witching’ Event on Friday
PremiumMarket News
Get Ready for a $5.7 Trillion ‘Triple-Witching’ Event on Friday
7d ago
DIA
PDD
Regeneron price target raised to $825 from $800 at Wells Fargo
PremiumThe Fly
Regeneron price target raised to $825 from $800 at Wells Fargo
7d ago
REGN
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
7d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
7d ago
AMGN
REGN
Regeneron and Sanofi Extend Phase 3 Itepekimab Program in Chronic Sinus Disease
PremiumCompany AnnouncementsRegeneron and Sanofi Extend Phase 3 Itepekimab Program in Chronic Sinus Disease
10d ago
SNY
REGN
Dupilumab Study Tracks Mental Health Benefits in Atopic Dermatitis Patients Across Gulf Countries
Premium
Company Announcements
Dupilumab Study Tracks Mental Health Benefits in Atopic Dermatitis Patients Across Gulf Countries
14d ago
SNY
REGN
Regeneron says Hansoh shares topline data from Phase 3 trial of olatorepatide
Premium
The Fly
Regeneron says Hansoh shares topline data from Phase 3 trial of olatorepatide
17d ago
REGN
Regeneron initiated with an Overweight at Barclays
PremiumThe Fly
Regeneron initiated with an Overweight at Barclays
20d ago
REGN
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
PremiumCompany Announcements
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
22d ago
REGN
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
PremiumMarket News
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
23d ago
NEM
SNY
Regeneron price target raised to $765 from $745 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $765 from $745 at RBC Capital
24d ago
SNY
REGN
Regeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent
PremiumThe FlyRegeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent
27d ago
SNY
REGN
Regeneron, Sanofi announce FDA approval of Dupixent for AFRS
Premium
The Fly
Regeneron, Sanofi announce FDA approval of Dupixent for AFRS
30d ago
SNY
REGN
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
Premium
Market News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
1M ago
BIB
CRBU
Regeneron announces FDA accepted Priority Review for BLA for garetosmab
PremiumThe Fly
Regeneron announces FDA accepted Priority Review for BLA for garetosmab
1M ago
REGN
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
1M ago
J
W
Regeneron Advances REGN7508 Into Phase 3 To Tackle Cancer-Linked Blood Clots
PremiumCompany Announcements
Regeneron Advances REGN7508 Into Phase 3 To Tackle Cancer-Linked Blood Clots
1M ago
REGN
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
PremiumCompany Announcements
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
1M ago
REGN
Regeneron and Sanofi Advance Kevzara Into Polymyalgia Rheumatica, Eyeing New Growth Channel
PremiumCompany AnnouncementsRegeneron and Sanofi Advance Kevzara Into Polymyalgia Rheumatica, Eyeing New Growth Channel
1M ago
SNY
REGN
Regeneron highlights expanding portfolio, pipeline at AAAI
Premium
The Fly
Regeneron highlights expanding portfolio, pipeline at AAAI
1M ago
SNY
REGN
Regeneron price target raised to $975 from $865 at Guggenheim
Premium
The Fly
Regeneron price target raised to $975 from $865 at Guggenheim
1M ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >